Morpho-functional indicators changes of rats’ myocardium in experimental doxorubicin-induced chronic heart failure and its pharmacological modulation with new 4-amino-1,2,4-triazole derivative

Bromide 1 - (β-phenylethyl)-4-amino-1,2,4-triazolium (Hypertril) has the properties of a beta-blocker and of NO-mimetic, is assigned to the IV class of toxicity. All these effects make Hypertril a promising drug for the treatment of cardiovascular diseases. The aim of this paper was to study the car...

Full description

Bibliographic Details
Main Authors: Pavlo G. Bak, Igor F. Belenichev, Liudmyla I. Kucherenko, Andrei V. Abramov, Olga V. Khromylоva
Format: Article
Language:English
Published: Pensoft Publishers 2021-12-01
Series:Pharmacia
Online Access:https://pharmacia.pensoft.net/article/75298/download/pdf/
_version_ 1818348317062463488
author Pavlo G. Bak
Igor F. Belenichev
Liudmyla I. Kucherenko
Andrei V. Abramov
Olga V. Khromylоva
author_facet Pavlo G. Bak
Igor F. Belenichev
Liudmyla I. Kucherenko
Andrei V. Abramov
Olga V. Khromylоva
author_sort Pavlo G. Bak
collection DOAJ
description Bromide 1 - (β-phenylethyl)-4-amino-1,2,4-triazolium (Hypertril) has the properties of a beta-blocker and of NO-mimetic, is assigned to the IV class of toxicity. All these effects make Hypertril a promising drug for the treatment of cardiovascular diseases. The aim of this paper was to study the cardioprotective action of Hypertril in terms of the effect on the morpho-functional parameters of the myocardium in rats with experimental chronic heart failure (CHF). CHF was modeled on 80 white outbred rats weighing 190–220g by administering doxorubicin at a cumulative dose of 15 mg/kg. Hypertril and the reference drug metoprolol succinate were administered within 30 days after CHF modeling, intragastrically at doses of 3.5 mg/kg and 15 mg/kg. Morphometric analysis of the cellular structure of the myocardium was carried out on an Axioskop microscope (Zeiss, Germany), in an automatic mode using a macro program developed in a specialized programming environment VIDAS-2.5 (Kontron Elektronik, Germany). The administration of Hypertril to animals with CHF led to an increase in the density of nuclei of cardiomyocytes, the area of myocardiocyte nuclei, an increase in the nuclear cytoplasmic ratio and an increase in the concentration of RNA in the nuclei and cytoplasm of cardiomyocytes compared with the group of untreated animals, which indicated the presence of a pronounced cardioprotective effect in the drug candidate. In terms of such indicators as the density of surviving cardiomyocytes and the content of RNA in them, the nuclear-cytoplasmic ratio of Hypertril is significantly (p < 0.05) superior to metoprolol.
first_indexed 2024-12-13T17:48:08Z
format Article
id doaj.art-cb1f9d85946e432685bea639457c2fbf
institution Directory Open Access Journal
issn 2603-557X
language English
last_indexed 2024-12-13T17:48:08Z
publishDate 2021-12-01
publisher Pensoft Publishers
record_format Article
series Pharmacia
spelling doaj.art-cb1f9d85946e432685bea639457c2fbf2022-12-21T23:36:35ZengPensoft PublishersPharmacia2603-557X2021-12-0168491992510.3897/pharmacia.68.e7529875298Morpho-functional indicators changes of rats’ myocardium in experimental doxorubicin-induced chronic heart failure and its pharmacological modulation with new 4-amino-1,2,4-triazole derivativePavlo G. Bak0Igor F. Belenichev1Liudmyla I. Kucherenko2Andrei V. Abramov3Olga V. Khromylоva4Zaporozhye State Medical UniversityZaporozhye State Medical University,Zaporozhye State Medical UniversityZaporozhye State Medical UniversityZaporozhye State Medical UniversityBromide 1 - (β-phenylethyl)-4-amino-1,2,4-triazolium (Hypertril) has the properties of a beta-blocker and of NO-mimetic, is assigned to the IV class of toxicity. All these effects make Hypertril a promising drug for the treatment of cardiovascular diseases. The aim of this paper was to study the cardioprotective action of Hypertril in terms of the effect on the morpho-functional parameters of the myocardium in rats with experimental chronic heart failure (CHF). CHF was modeled on 80 white outbred rats weighing 190–220g by administering doxorubicin at a cumulative dose of 15 mg/kg. Hypertril and the reference drug metoprolol succinate were administered within 30 days after CHF modeling, intragastrically at doses of 3.5 mg/kg and 15 mg/kg. Morphometric analysis of the cellular structure of the myocardium was carried out on an Axioskop microscope (Zeiss, Germany), in an automatic mode using a macro program developed in a specialized programming environment VIDAS-2.5 (Kontron Elektronik, Germany). The administration of Hypertril to animals with CHF led to an increase in the density of nuclei of cardiomyocytes, the area of myocardiocyte nuclei, an increase in the nuclear cytoplasmic ratio and an increase in the concentration of RNA in the nuclei and cytoplasm of cardiomyocytes compared with the group of untreated animals, which indicated the presence of a pronounced cardioprotective effect in the drug candidate. In terms of such indicators as the density of surviving cardiomyocytes and the content of RNA in them, the nuclear-cytoplasmic ratio of Hypertril is significantly (p < 0.05) superior to metoprolol.https://pharmacia.pensoft.net/article/75298/download/pdf/
spellingShingle Pavlo G. Bak
Igor F. Belenichev
Liudmyla I. Kucherenko
Andrei V. Abramov
Olga V. Khromylоva
Morpho-functional indicators changes of rats’ myocardium in experimental doxorubicin-induced chronic heart failure and its pharmacological modulation with new 4-amino-1,2,4-triazole derivative
Pharmacia
title Morpho-functional indicators changes of rats’ myocardium in experimental doxorubicin-induced chronic heart failure and its pharmacological modulation with new 4-amino-1,2,4-triazole derivative
title_full Morpho-functional indicators changes of rats’ myocardium in experimental doxorubicin-induced chronic heart failure and its pharmacological modulation with new 4-amino-1,2,4-triazole derivative
title_fullStr Morpho-functional indicators changes of rats’ myocardium in experimental doxorubicin-induced chronic heart failure and its pharmacological modulation with new 4-amino-1,2,4-triazole derivative
title_full_unstemmed Morpho-functional indicators changes of rats’ myocardium in experimental doxorubicin-induced chronic heart failure and its pharmacological modulation with new 4-amino-1,2,4-triazole derivative
title_short Morpho-functional indicators changes of rats’ myocardium in experimental doxorubicin-induced chronic heart failure and its pharmacological modulation with new 4-amino-1,2,4-triazole derivative
title_sort morpho functional indicators changes of rats myocardium in experimental doxorubicin induced chronic heart failure and its pharmacological modulation with new 4 amino 1 2 4 triazole derivative
url https://pharmacia.pensoft.net/article/75298/download/pdf/
work_keys_str_mv AT pavlogbak morphofunctionalindicatorschangesofratsmyocardiuminexperimentaldoxorubicininducedchronicheartfailureanditspharmacologicalmodulationwithnew4amino124triazolederivative
AT igorfbelenichev morphofunctionalindicatorschangesofratsmyocardiuminexperimentaldoxorubicininducedchronicheartfailureanditspharmacologicalmodulationwithnew4amino124triazolederivative
AT liudmylaikucherenko morphofunctionalindicatorschangesofratsmyocardiuminexperimentaldoxorubicininducedchronicheartfailureanditspharmacologicalmodulationwithnew4amino124triazolederivative
AT andreivabramov morphofunctionalindicatorschangesofratsmyocardiuminexperimentaldoxorubicininducedchronicheartfailureanditspharmacologicalmodulationwithnew4amino124triazolederivative
AT olgavkhromylova morphofunctionalindicatorschangesofratsmyocardiuminexperimentaldoxorubicininducedchronicheartfailureanditspharmacologicalmodulationwithnew4amino124triazolederivative